Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Total Liabilities (2016 - 2026)

Nrc Health's Total Liabilities history spans 16 years, with the latest figure at $120.9 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 19.39% to $120.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $120.9 million, a 19.39% increase, with the full-year FY2025 number at $120.9 million, up 19.39% from a year prior.
  • Total Liabilities hit $120.9 million in Q4 2025 for Nrc Health, roughly flat from $121.4 million in the prior quarter.
  • Over the last five years, Total Liabilities for NRC hit a ceiling of $121.4 million in Q3 2025 and a floor of $55.9 million in Q2 2023.
  • Historically, Total Liabilities has averaged $82.0 million across 5 years, with a median of $73.6 million in 2021.
  • Biggest five-year swings in Total Liabilities: dropped 19.08% in 2022 and later skyrocketed 56.07% in 2024.
  • Tracing NRC's Total Liabilities over 5 years: stood at $72.2 million in 2021, then fell by 19.08% to $58.4 million in 2022, then grew by 25.77% to $73.5 million in 2023, then soared by 37.8% to $101.3 million in 2024, then rose by 19.39% to $120.9 million in 2025.
  • Business Quant data shows Total Liabilities for NRC at $120.9 million in Q4 2025, $121.4 million in Q3 2025, and $120.1 million in Q2 2025.